In the diabetes trial published in The Lancet in June 2026, retatrutide as a first drug drove blood sugar to near-normal levels in early type 2 diabetes while taking off 15.3 percent of body weight
Description BPC 157 is not a steroid.It is a synthetic peptide derived from a protective protein and helps alleviate joint pain, injuries, and those looking to improve joint mobility
Century Therapeutics Founded: 2018 Technology / disease area: Allogeneic iPSC-derived cell therapies in autoimmune disease, cancer, and more recently type 1 diabetes Lead candidate: CNTY-813 Century Therapeutics is built around induced pluripotent stem cells (iPSCs) as a renewable starting material for off-the-shelf immune and tissue cell products
Thats why you wont find professional organizations like the American Diabetes Association recommending it
Michael Lincoff, MD, Cleveland Clinic, lead author of SELECT [1] changed how we think about these medications." Undereating is a real problem on GLP-1 treatment